X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Elder Pharma with Strides Arcolab - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs STRIDES SHASUN LTD - Comparison Results

STRIDES SHASUN LTD 
   Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA STRIDES SHASUN LTD ELDER PHARMA/
STRIDES SHASUN LTD
 
P/E (TTM) x -0.2 14.1 - View Chart
P/BV x 0.1 1.9 5.3% View Chart
Dividend Yield % 0.0 0.5 -  

Financials

 ELDER PHARMA   STRIDES SHASUN LTD
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
STRIDES SHASUN LTD
Mar-16
ELDER PHARMA/
STRIDES SHASUN LTD
5-Yr Chart
Click to enlarge
High Rs3801,413 26.9%   
Low Rs188848 22.2%   
Sales per share (Unadj.) Rs491.2353.3 139.0%  
Earnings per share (Unadj.) Rs-3.223.4 -13.6%  
Cash flow per share (Unadj.) Rs14.441.0 35.2%  
Dividends per share (Unadj.) Rs05.00 0.0%  
Dividend yield (eoy) %00.4 0.0%  
Book value per share (Unadj.) Rs376.5320.4 117.5%  
Shares outstanding (eoy) m20.5489.35 23.0%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x0.63.2 18.1%   
Avg P/E ratio x-89.348.3 -184.7%  
P/CF ratio (eoy) x19.727.6 71.5%  
Price / Book Value ratio x0.83.5 21.4%  
Dividend payout %021.4 0.0%   
Avg Mkt Cap Rs m5,833100,988 5.8%   
No. of employees `000NA4.7 0.0%   
Total wages/salary Rs m2,1794,988 43.7%   
Avg. sales/employee Rs ThNM6,730.0-  
Avg. wages/employee Rs ThNM1,063.6-  
Avg. net profit/employee Rs ThNM445.5-  
INCOME DATA
Net Sales Rs m10,08931,564 32.0%  
Other income Rs m2571,212 21.2%   
Total revenues Rs m10,34632,776 31.6%   
Gross profit Rs m-7925,213 -15.2%  
Depreciation Rs m3611,573 23.0%   
Interest Rs m2,7561,803 152.9%   
Profit before tax Rs m-3,6533,049 -119.8%   
Minority Interest Rs m0127 0.0%   
Prior Period Items Rs m0-27 0.0%   
Extraordinary Inc (Exp) Rs m3,713-371 -1,000.9%   
Tax Rs m125689 18.2%   
Profit after tax Rs m-652,089 -3.1%  
Gross profit margin %-7.816.5 -47.5%  
Effective tax rate %-3.422.6 -15.2%   
Net profit margin %-0.66.6 -9.8%  
BALANCE SHEET DATA
Current assets Rs m9,24035,949 25.7%   
Current liabilities Rs m9,99819,402 51.5%   
Net working cap to sales %-7.552.4 -14.3%  
Current ratio x0.91.9 49.9%  
Inventory Days Days4671 65.3%  
Debtors Days Days60127 47.3%  
Net fixed assets Rs m10,12434,478 29.4%   
Share capital Rs m206894 23.0%   
"Free" reserves Rs m5,58222,601 24.7%   
Net worth Rs m7,73428,632 27.0%   
Long term debt Rs m4,88927,455 17.8%   
Total assets Rs m22,88276,591 29.9%  
Interest coverage x-0.32.7 -12.1%   
Debt to equity ratio x0.61.0 65.9%  
Sales to assets ratio x0.40.4 107.0%   
Return on assets %11.85.1 231.4%  
Return on equity %-0.87.3 -11.6%  
Return on capital %22.38.2 273.1%  
Exports to sales %3.048.1 6.3%   
Imports to sales %0.414.5 3.0%   
Exports (fob) Rs m30715,192 2.0%   
Imports (cif) Rs m434,565 0.9%   
Fx inflow Rs m30716,612 1.8%   
Fx outflow Rs m1255,292 2.4%   
Net fx Rs m18111,320 1.6%   
CASH FLOW
From Operations Rs m11,754717 1,640.3%  
From Investments Rs m-561-22,284 2.5%  
From Financial Activity Rs m-6,76229,488 -22.9%  
Net Cashflow Rs m4,4328,073 54.9%  

Share Holding

Indian Promoters % 39.6 27.7 143.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.5 37.8 19.8%  
FIIs % 16.8 8.6 195.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 25.9 139.4%  
Shareholders   16,479 56,241 29.3%  
Pledged promoter(s) holding % 77.6 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   GSK PHARMA  ASTRAZENECA PHARMA  BIOCON LTD  PIRAMAL ENTERPRISES  NATCO PHARMA  

Compare ELDER PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Tata Global Beverages Surges 8.3%(Closing)

Indian share markets snapped their losing streak of last week and finished the trading day on a strong note due to strong buying momentum in FMCG stocks, metal stocks and auto stocks.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA 5-YR ANALYSIS

COMPARE ELDER PHARMA WITH

MARKET STATS